Key takeaways
- Purity describes the composition of the peptide fraction; net peptide content describes what fraction of the total powder is peptide at all.
- Lyophilized peptides carry counter-ions from purification, usually trifluoroacetate, plus bound water, and together these commonly account for 10 to 30 percent of the weighed mass.
- Amino-acid analysis after acid hydrolysis is the reference method for net content because it counts the peptide’s constituent residues directly rather than relying on a calibration standard of the same peptide.
- A COA that reports purity without net content leaves the actual peptide quantity in the vial undefined, which matters for any experiment that depends on concentration.
Two figures on a peptide certificate of analysis are routinely confused, and the confusion is costly because they measure unrelated things. Purity, usually from HPLC, is a statement about quality: of the peptide-like material in the sample, how much is the intended sequence. Net peptide content is a statement about quantity: of the powder in the vial, how much is peptide of any kind, as opposed to salt, water and other non-peptide mass. A sample can score 99 percent on the first and 70 percent on the second without any contradiction. Researchers who weigh out a lyophilized peptide and assume the mass on the balance is the mass of peptide are frequently off by a quarter or more, and the error propagates into every concentration they calculate afterwards. This note explains where the non-peptide mass comes from, why it is unavoidable, how it is measured, and what a well-constructed COA should say about it.
What purity measures and what it leaves out
An HPLC purity figure is derived from a chromatogram. The sample is dissolved, injected onto a column, and the compounds in it elute at different times according to their affinity for the stationary phase. A detector, usually ultraviolet absorbance at a wavelength where the peptide backbone absorbs, records a signal as each compound passes. Purity is the area of the main peak divided by the total area of all peaks, expressed as a percentage. The method is explained in detail in our note on what HPLC measures.
Notice what that calculation includes and excludes. It includes anything that absorbs UV light at the detection wavelength and elutes from the column, which in practice means the target peptide and its peptide-like impurities. It excludes anything that does not absorb at that wavelength or does not elute in the analytical window. Water does not absorb at 214 or 220 nanometers. Trifluoroacetate absorbs only weakly and typically elutes with the solvent front, outside the integrated region. Sodium, chloride and acetate ions are invisible to the detector. So a purity figure is, by construction, a description of the peptide fraction only. It is silent about how large that fraction is relative to the whole sample.
Where the non-peptide mass comes from
Three components account for nearly all of the difference between weighed mass and peptide mass in a lyophilized product.
Counter-ions
Peptides carry charged groups: the N-terminal amine, the side chains of lysine, arginine and histidine, and, on the acidic side, the C-terminal carboxylate and the side chains of aspartate and glutamate. In the solid state, every positive charge must be paired with a negative counter-ion and vice versa. Which counter-ion depends on the last acidic or basic environment the peptide saw. In standard solid-phase synthesis, the final cleavage from the resin uses concentrated trifluoroacetic acid (TFA), and preparative HPLC purification typically runs in mobile phases containing 0.1 percent TFA. The peptide therefore emerges as a trifluoroacetate salt, with one TFA anion (formula weight 113) for each basic site.1 For a peptide with several arginine and lysine residues, the TFA alone can be 10 to 15 percent of the total mass. Some manufacturers exchange TFA for acetate or chloride, which are lighter and sometimes preferred for biological work, but a counter-ion of some kind is always present; a peptide cannot exist as a neutral solid with unpaired charges.
Counter-ion identity is not only a mass question. Cornish and colleagues showed that trifluoroacetate at concentrations found in typical purified peptide preparations inhibited the proliferation of osteoblasts and chondrocytes in culture, an effect independent of the peptide itself.2 This is why some cell-based research protocols specify acetate or hydrochloride salts, and why a COA that names the salt form is more useful than one that does not.
Water
Lyophilization removes bulk water but not all of it. Peptides are hygroscopic, and a freeze-dried cake retains water bound to polar groups and readily absorbs more from the atmosphere when a vial is opened or if the stopper seal is imperfect. Residual water in lyophilized peptides commonly ranges from a few percent to more than 10 percent by mass depending on the sequence, the lyophilization cycle and the storage history.3 Unlike counter-ions, the water fraction is not fixed; it can rise over time, which is one reason net content is best measured close to the time of use for demanding applications. The compendial method for water is Karl Fischer titration, described in USP General Chapter <921> which reacts water quantitatively with iodine and is specific for it, unlike simple loss-on-drying which also removes volatile solvents.
Residual solvents and excipients
Small amounts of acetonitrile or other organic solvents from purification may remain after lyophilization. Some formulations also include a bulking agent such as mannitol to give the lyophilized cake structure, and where present this can be a substantial fraction of the total mass. A COA should list any excipient, because a vial labeled by total mass that contains a bulking agent will have correspondingly less peptide.
| Component | Typical share of weighed mass | Detected by HPLC purity? | Reference method |
|---|---|---|---|
| Target peptide | 65–90% | Yes (main peak) | Amino-acid analysis |
| Peptide-related impurities | 0.5–5% | Yes (minor peaks) | HPLC, LC-MS |
| Counter-ions (TFA, acetate, chloride) | 5–20% | No | Ion chromatography, fluorine NMR |
| Water | 2–12% | No | Karl Fischer titration (USP <921>) |
| Residual solvents | <1% | No | Gas chromatography (USP <467>) |
Purity tells you how good the peptide is. Net content tells you how much of it you have. Neither number can stand in for the other.
How net peptide content is measured
There are two general strategies for determining what fraction of a powder is peptide. The first is subtraction, often called the mass-balance approach: measure the water, the counter-ions and the residual solvents separately, sum them, and assign what remains to peptide. This is the approach metrology institutes use to certify reference materials, and Josephs and colleagues reviewed its application to peptides in detail.4 It is rigorous but requires several orthogonal measurements and is rarely applied in full to research-grade material.
The second strategy is direct measurement of the peptide, and its reference method is amino-acid analysis (AAA). The peptide is hydrolyzed in strong acid, typically 6 molar hydrochloric acid at 110 degrees Celsius for around 24 hours, which breaks every peptide bond and releases the constituent amino acids. The free amino acids are then separated and quantified, usually by ion-exchange or reversed-phase chromatography after derivatization, against certified amino-acid standards. Because the sequence is known, the number of moles of each stable amino acid recovered can be converted to moles of peptide, and from there to the mass of peptide in the hydrolyzed sample.5 Dividing by the mass weighed gives the net peptide content.
AAA has a particular strength: it does not require a reference standard of the same peptide. The calibration is against individual amino acids, which are inexpensive, stable and available at certified purity. This makes AAA the method of choice for new or uncommon sequences. It also has known limitations. Tryptophan is destroyed by acid hydrolysis, asparagine and glutamine are converted to aspartate and glutamate, and serine and threonine are partially lost, so quantitation relies on the stable residues and applies correction factors or excludes labile ones. USP General Chapter <1052> sets out the methodology for biotechnology-derived products and discusses these corrections.
Other approaches
Ultraviolet absorbance at 280 nanometers can estimate peptide concentration if the sequence contains tryptophan or tyrosine, using calculated extinction coefficients, but it is less accurate than AAA and cannot be used for peptides lacking aromatic residues. Nitrogen determination by combustion or Kjeldahl analysis measures total nitrogen and converts it to peptide via the sequence’s nitrogen content, but it is confounded by any nitrogen-containing impurity. Quantitative NMR is increasingly used in reference-material work and has the advantage of measuring the intact peptide against an unrelated internal standard. In commercial research-peptide testing, AAA remains the most commonly reported method, and when a COA lists net peptide content, AAA is usually the source.
What this means for a labeled quantity
A vial labeled “10 mg” may be labeled by gross lyophilized mass or by peptide content, and the two conventions give different amounts of peptide. If the label reflects gross mass and the net content is 80 percent, the vial contains roughly 8 mg of peptide. If the label reflects peptide content, the manufacturer has weighed in more than 10 mg of powder to deliver 10 mg of peptide, and the COA should show a net content result that supports the claim. Neither convention is wrong, but they are not interchangeable, and a supplier should state which one applies. The practical consequence for a researcher is that any concentration calculated from the labeled mass inherits whatever uncertainty the label carries. Hoofnagle and colleagues, writing for laboratories that build quantitative mass-spectrometry assays around synthetic peptides, recommended that peptide content be determined by AAA rather than assumed from the supplier’s gross weight, because the variance they observed across commercial lots was large enough to invalidate calibration curves.3
Reading the evidence
When both figures appear on a COA, multiply them. A vial reported at 98 percent purity and 82 percent net peptide content contains, per milligram weighed, about 0.80 milligrams of the target sequence. When only purity appears, the peptide mass is undefined until net content is measured. Wednesday’s third-party reports are published per lot in the COA library; the guide to reading a COA shows where each figure sits on the document.
Why both numbers belong on a certificate
The two measurements protect against different failures. High purity with low net content is the common case: a well-purified peptide that is simply heavy with TFA and water. It is not a quality problem, but it is a quantity problem if the label is read naively. Low purity with high net content is rarer but worse: the vial is mostly peptide, but a meaningful share of that peptide is the wrong sequence, and no amount of accurate weighing will correct for it. Only reporting both allows a reader to distinguish these situations. The impurity classes that reduce purity are catalogued in D’Hondt and colleagues’ review, and none of them are visible in a net-content result; conversely, the counter-ion and water fractions that reduce net content are invisible in a chromatogram.6
For research purposes, the distinction is not academic. Concentration-dependent experiments, from receptor-binding assays to dose-response curves in cell culture, are only interpretable if the concentration is known. A peptide of 99 percent purity whose actual mass is 25 percent lower than assumed will produce a dose-response curve shifted by 25 percent, and the shift will look like a property of the compound rather than an artifact of the weighing. Independent testing that reports both figures, discussed in our note on why third-party testing matters, is what makes that error avoidable.
Frequently asked questions
What is net peptide content?
Net peptide content is the percentage of a lyophilized powder’s mass that is actually peptide, as opposed to counter-ions, water and residual solvents. It is usually measured by amino-acid analysis and commonly falls between 65 and 90 percent for research peptides.
Why is peptide purity different from peptide content?
Purity describes the composition of the peptide fraction: how much of the peptide-like material is the correct sequence. Content describes how large that fraction is relative to the whole powder. HPLC purity does not detect water or salts, so it cannot report content.
What is TFA in peptides and why is it there?
Trifluoroacetic acid is used to cleave peptides from the synthesis resin and in HPLC purification. The peptide emerges as a trifluoroacetate salt, with one TFA anion per basic site. TFA adds mass to the vial and has been shown to affect some cell types in culture, so some suppliers exchange it for acetate or chloride.
How is net peptide content measured?
The reference method is amino-acid analysis: the peptide is hydrolyzed in acid, the released amino acids are quantified against standards, and the result is converted to peptide mass using the known sequence. Mass-balance approaches that measure water, counter-ions and solvents separately are also used.
Does a 10 mg peptide vial contain 10 mg of peptide?
Not necessarily. If the vial is labeled by gross lyophilized mass, the peptide content will be lower by the counter-ion and water fraction, often 10 to 30 percent. If it is labeled by peptide content, the COA should show a net content result supporting the figure. Suppliers should state which convention they use.
References & further reading
- Roux S, Zékri E, Rousseau B, Paternostre M, Cintrat JC, Fay N. Elimination and exchange of trifluoroacetate counter-ion from cationic peptides: a critical evaluation of different approaches. J Pept Sci. 2008;14(3):354-359. doi:10.1002/psc.951 / PMID 18035848
- Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 1999;277(5):E779-E783. doi:10.1152/ajpendo.1999.277.5.E779 / PMID 10567002
- Hoofnagle AN, Whiteaker JR, Carr SA, et al. Recommendations for the generation, quantification, storage, and handling of peptides used for mass spectrometry-based assays. Clin Chem. 2016;62(1):48-69. doi:10.1373/clinchem.2015.250563 / PMID 26719571
- Josephs RD, et al. Establishment of measurement traceability for peptide and protein quantification through rigorous purity assessment, a review. Metrologia. 2019;56(4):044006. doi:10.1088/1681-7575/ab27e5
- Rutherfurd SM, Gilani GS. Amino acid analysis. Curr Protoc Protein Sci. 2009;Chapter 11:Unit 11.9. doi:10.1002/0471140864.ps1109s58
- D’Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. doi:10.1016/j.jpba.2014.06.012 / PMID 25044089